(MedPage Today) -- The FDA approved the autoinjector version of lerodalcibep (Lerochol), a PCSK9 inhibitor for LDL cholesterol lowering, LIB Therapeutics announced. Bracco Imaging announced FDA clearance of its VueJect contrast delivery system...